Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer

Androgen receptor splice variant-7 (AR-V7) expression in circulating tumor cells (CTCs) in metastatic castration-resistant prostate cancer (mCRPC) is associated with abiraterone and enzalutamide resistance. We determine whether cabazitaxel (CBZ) is equally effective in AR-V7-positive and -negative C...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashizawa, Takeshi, Nagata, Masayoshi, Nakamura, So, Hirano, Hisashi, Nagaya, Naoya, Lu, Yan, Horie, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606294/
https://www.ncbi.nlm.nih.gov/pubmed/36289357
http://dx.doi.org/10.1038/s41598-022-22854-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606294/
https://www.ncbi.nlm.nih.gov/pubmed/36289357
http://dx.doi.org/10.1038/s41598-022-22854-1

Ejemplares similares